101 related articles for article (PubMed ID: 21726302)
1. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
Burkard T; Kaiser CA; Brunner-La Rocca H; Osswald S; Pfisterer ME; Jeger RV;
J Intern Med; 2012 Mar; 271(3):257-63. PubMed ID: 21726302
[TBL] [Abstract][Full Text] [Related]
2. Impact of Proton-pump Inhibitors on the Pharmacodynamic Effect and Clinical Outcomes in Patients Receiving Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: A Propensity Score Analysis.
Zhu P; Gao Z; Tang XF; Xu JJ; Zhang Y; Gao LJ; Chen J; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
Chin Med J (Engl); 2017 Dec; 130(24):2899-2905. PubMed ID: 29237921
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of proton pump inhibitors on cardiovascular events and inflammatory factors in patients with upper gastrointestinal bleeding undergoing dual antiplatelet therapy.
Yang S; Shi L
Inflammopharmacology; 2024 Jun; 32(3):1999-2006. PubMed ID: 38642222
[TBL] [Abstract][Full Text] [Related]
4. Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease.
Pello Lázaro AM; Cristóbal C; Franco-Peláez JA; Tarín N; Aceña Á; Carda R; Huelmos A; Martín-Mariscal ML; Fuentes-Antras J; Martínez-Millá J; Alonso J; Lorenzo Ó; Egido J; López-Bescós L; Tuñón J
PLoS One; 2017; 12(1):e0169826. PubMed ID: 28103324
[TBL] [Abstract][Full Text] [Related]
5. PPIs Are Not Responsible for Elevating Cardiovascular Risk in Patients on Clopidogrel-A Systematic Review and Meta-Analysis.
Demcsák A; Lantos T; Bálint ER; Hartmann P; Vincze Á; Bajor J; Czopf L; Alizadeh H; Gyöngyi Z; Márta K; Mikó A; Szakács Z; Pécsi D; Hegyi P; Szabó IL
Front Physiol; 2018; 9():1550. PubMed ID: 30510515
[No Abstract] [Full Text] [Related]
6. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.
Goodman SG; Clare R; Pieper KS; Nicolau JC; Storey RF; Cantor WJ; Mahaffey KW; Angiolillo DJ; Husted S; Cannon CP; James SK; Kilhamn J; Steg PG; Harrington RA; Wallentin L;
Circulation; 2012 Feb; 125(8):978-86. PubMed ID: 22261200
[TBL] [Abstract][Full Text] [Related]
7. Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.
Bhurke SM; Martin BC; Li C; Franks AM; Bursac Z; Said Q
Pharmacotherapy; 2012 Sep; 32(9):809-18. PubMed ID: 22744772
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
Vaduganathan M; Cannon CP; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Bhatt DL;
Am J Med; 2016 Sep; 129(9):1002-5. PubMed ID: 27143321
[TBL] [Abstract][Full Text] [Related]
9. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
[TBL] [Abstract][Full Text] [Related]
10. Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.
Dunn SP; Steinhubl SR; Bauer D; Charnigo RJ; Berger PB; Topol EJ
J Am Heart Assoc; 2013 Jan; 2(1):e004564. PubMed ID: 23525436
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes following coronary stenting in Japanese patients treated with and without proton pump inhibitor.
Chitose T; Hokimoto S; Oshima S; Nakao K; Fujimoto K; Miyao Y; Shimomura H; Tsunoda R; Maruyama H; Hirose T; Yamamoto K; Mizobe M; Kaikita K; Nakamura S; Ogawa H;
Circ J; 2012; 76(1):71-8. PubMed ID: 22130313
[TBL] [Abstract][Full Text] [Related]
12. Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Drug-Eluting Stent Implantation: A Nationwide Cohort Study.
Hsieh CF; Huang WF; Chiang YT; Chen CY
PLoS One; 2015; 10(8):e0135915. PubMed ID: 26313000
[TBL] [Abstract][Full Text] [Related]
13. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
Arbel Y; Birati EY; Finkelstein A; Halkin A; Kletzel H; Abramowitz Y; Berliner S; Deutsch V; Herz I; Keren G; Banai S
Clin Cardiol; 2013 Jun; 36(6):342-6. PubMed ID: 23630016
[TBL] [Abstract][Full Text] [Related]
14. Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review.
Sherwood MW; Melloni C; Jones WS; Washam JB; Hasselblad V; Dolor RJ
J Am Heart Assoc; 2015 Oct; 4(11):. PubMed ID: 26514161
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis.
Cardoso RN; Benjo AM; DiNicolantonio JJ; Garcia DC; Macedo FY; El-Hayek G; Nadkarni GN; Gili S; Iannaccone M; Konstantinidis I; Reilly JP
Open Heart; 2015; 2(1):e000248. PubMed ID: 26196021
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors and the risk of adverse cardiac events.
Juurlink DN; Dormuth CR; Huang A; Hellings C; Paterson JM; Raymond C; Kozyrskyj A; Moride Y; Macdonald EM; Mamdani MM
PLoS One; 2013; 8(12):e84890. PubMed ID: 24386430
[TBL] [Abstract][Full Text] [Related]
17. Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care.
García Rodríguez LA; Johansson S; Nagy P; Cea Soriano L
Thromb Haemost; 2014 Jan; 111(1):131-9. PubMed ID: 24153412
[TBL] [Abstract][Full Text] [Related]
18. Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study.
Yano H; Tsukahara K; Morita S; Endo T; Sugano T; Hibi K; Himeno H; Fukui K; Umemura S; Kimura K
Circ J; 2012; 76(11):2673-80. PubMed ID: 22864179
[TBL] [Abstract][Full Text] [Related]
19. Adverse cardiovascular effects of concomitant use of proton pump inhibitors and clopidogrel in patients with coronary artery disease: a systematic review and meta-analysis.
Huang B; Huang Y; Li Y; Yao H; Jing X; Huang H; Li J
Arch Med Res; 2012 Apr; 43(3):212-24. PubMed ID: 22564422
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
